Boldenone and CJC-1295 (without DAC) Interaction

Synergistic
Mechanism-based 60% confidence

Boldenone and CJC-1295 (without DAC) have a synergistic interaction with 60% confidence. CJC-1295 (without DAC) helps manage estrogen conversion from Boldenone. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. These compounds primarily affect different organ systems.

Compound Profiles

Boldenone

Anabolic-Androgenic Steroid | Lean Mass & Vascularity

Boldenone exerts its anabolic effects primarily through binding to the androgen receptor (AR), promoting nitrogen retention, protein synthesis, and increased IGF-1 output in muscle tissue. The 1,2-double bond modification reduces the compound's affinity for 5-alpha reductase, meaning boldenone is not efficiently converted to a more potent dihydro-metabolite in the way testosterone is converted to DHT.

Half-life: ~14 days (undecylenate) Typical dose: 200-400 mg/week (moderate) anabolic
5 alpha reductaseandrogen receptoraromataseepo receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
Liver
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (Boldenone, CJC-1295 (without DAC)). Monitor accordingly.
2x 2 estrogenic compounds (Boldenone, CJC-1295 (without DAC)). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 compounds share the teratogenic safety flag (Boldenone, CJC-1295 (without DAC)). Monitor accordingly.

Frequently Asked Questions

Can I take Boldenone with CJC-1295 (without DAC)?

Yes, Boldenone and CJC-1295 (without DAC) can generally be taken together. CJC-1295 (without DAC) helps manage estrogen conversion from Boldenone. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is Boldenone and CJC-1295 (without DAC) safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, estrogenic, teratogenic. Monitor accordingly.

What are the interactions between Boldenone and CJC-1295 (without DAC)?

CJC-1295 (without DAC) helps manage estrogen conversion from Boldenone. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.

How should I time Boldenone and CJC-1295 (without DAC)?

Boldenone has a half-life of ~14 days (undecylenate) and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Boldenone vs CJC-1295 (without DAC)

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.